Skip to main content

Post-IPO Equity Pharmaceutical Companies

Explore 203 pharmaceutical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
203
Total Funding
$2.1B
Avg Funding
$84.6M
Cities
21

Export 203 Post-IPO Equity Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Toronto, Canada
$50.0M
raised

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$380.0M
raised

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$393K
raised

New treatment for blood diseases, such as leukemia and lymphoma.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Florida, United States
$5.3M
raised

Nutriband is an innovative and progressive health and lifestyle company.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$110.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Dallas, United States
$4.0M
raised

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Edmonton, Canada
$25.0M
raised

Aurora Cannabis is a medical marijuana producer that provides its patients quality products, customer service, and affordable pricing.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$12.9M
raised

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$7.9M
raised

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$100.0M
raised

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$27.0M
raised

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Sep 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Baltimore, United States
$7.0M
raised

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bromma, Sweden
$3.1M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$754K
raised

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$100.0M
raised

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Salt Lake City, United States
$4.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$100K
raised

Sproutly is the supplier of unique ingredients and customized formulations to the cannabis beverage and edibles market.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$690.0M
raised

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$500K
raised

Allied produces premium craft cannabinoid health products that support PTSI patients.

Aug 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 203 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pointe-claire, Canada
$1.7M
raised

Devonian is a late stage botanical pharmaceutical corporation

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wexford, United States
$4.0M
raised

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melville, United States
$400.0M
raised

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Westbrook, United States
$4.4M
raised

One of the most innovative consumer healthcare and beauty companies in North America.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malvern, United States
$1.9M
raised

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 203 companies

Ready to Connect with Post-IPO Equity Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 203 post-ipo equity pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked